These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 10979055)

  • 1. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?
    Grossman E; Messerli FH; Goldbourt U
    Arch Intern Med; 2000 Sep; 160(16):2447-52. PubMed ID: 10979055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive therapy in diabetic hypertensive patients.
    Messerli FH; Grossman E; Goldbourt U
    Am J Hypertens; 2001 May; 14(5 Pt 2):12S-16S. PubMed ID: 11370955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are calcium antagonists beneficial in diabetic patients with hypertension?
    Grossman E; Messerli FH
    Am J Med; 2004 Jan; 116(1):44-9. PubMed ID: 14706665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care.
    Vijan S; Hayward RA
    Ann Intern Med; 2003 Apr; 138(7):593-602. PubMed ID: 12667032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.
    Wu HY; Huang JW; Lin HJ; Liao WC; Peng YS; Hung KY; Wu KD; Tu YK; Chien KL
    BMJ; 2013 Oct; 347():f6008. PubMed ID: 24157497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term safety of antihypertensive therapy.
    Grossman E; Messerli FH
    Prog Cardiovasc Dis; 2006; 49(1):16-25. PubMed ID: 16867847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review on the Efficacy of Amlodipine in the Treatment of Patients With Hypertension With Concomitant Diabetes Mellitus and/or Renal Dysfunction, When Compared With Other Classes of Antihypertensive Medication.
    Jeffers BW; Robbins J; Bhambri R; Wajsbrot D
    Am J Ther; 2015; 22(5):322-41. PubMed ID: 25738570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood pressure control, microalbuminuria and cardiovascular risk in Type 2 diabetes mellitus.
    Marshall SM
    Diabet Med; 1999 May; 16(5):358-72. PubMed ID: 10342335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-line drugs for hypertension.
    Wright JM; Musini VM
    Cochrane Database Syst Rev; 2009 Jul; (3):CD001841. PubMed ID: 19588327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult hypertension: reducing cardiovascular morbidity and mortality.
    Prescrire Int; 2005 Feb; 14(75):25-33. PubMed ID: 15751180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.
    Wang G; Chen Y; Li L; Tang W; Wright JM
    J Hum Hypertens; 2018 Jul; 32(7):494-506. PubMed ID: 29713053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
    Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
    JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review: antihypertensive drug therapy in black patients.
    Brewster LM; van Montfrans GA; Kleijnen J
    Ann Intern Med; 2004 Oct; 141(8):614-27. PubMed ID: 15492341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.